We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Stryker Commits to Buy Physio-Control International

By HospiMedica International staff writers
Posted on 06 Mar 2016
Medical device maker Stryker Corporation (Kalamazoo, MI, USA) will buy Physio-Control International (Redmond, WA, USA) for USD 1.28 billion in a bid to expand its emergency medical services (EMS) business.

Physio-Control, currently a portfolio company of Bain Capital Private Equity (New York, NY, USA), develops, manufactures, and markets monitors, defibrillators, automated external defibrillators (AEDs), and cardiopulmonary resuscitation (CPR)-assist devices, along with data management and support services. More...
The company's portfolio, which is highly complementary to Stryker's EMS offering, is expected to create a greater balance between capital and disposables in the company, and is also projected to expand Stryker's global footprint by promoting an enhanced presence and infrastructure.

“Physio-Control has achieved global leadership positions with a strong brand and customer centered solutions that can predict or intervene in life-threatening emergencies,” said Kevin Lobo, Chairman and CEO of Stryker. “Physio-Control's focused strategy and their culture will fit well within the EMS business of our Medical division, further leveraging our existing call pattern. We look forward to welcoming the Physio-Control team to Stryker.”

“Joining Stryker is an exciting next step in the evolution of Physio-Control for both our team and our customers,” said Brian Webster, President and CEO of PhysioControl. “Stryker has a deep understanding of capital equipment and of our core market segments. We will build on the success our team has achieved in partnership with Bain Capital, and further accelerate the execution of our strategy, including continued investment in great product solutions for our customers.”

“It has been a privilege to work collaboratively with Brian and the management team as the company has shown great progress and built even more enduring customer loyalty,” said Chris Gordon, a managing director at Bain Capital Private Equity. “Physio-Control has added significant operational strength and made substantial investments in R&D to accelerate the development and launch of its next generation product lines. We believe the business is well positioned for further growth, and are confident that Physio-Control will continue to thrive under Stryker's ownership.”

Stryker has been following an aggressive acquisition-driven strategy to boost growth over the last three years, resulting in a total of 12 targeted deals that have greatly expanded its product portfolio, the latest being the purchase of Sage Products (Cary, IL, USA) for USD 2.775 billion in cash in January 2016.

Related Links:
Stryker Corporation
Physio-Control International
Bain Capital Private Equity



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Syringes
Prefilled Saline Flush Syringes
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.